| Literature DB >> 25316188 |
Rodolfo Montironi1, Elizabeth H Hammond, Daniel W Lin, John L Gore, John R Srigley, Hema Samaratunga, Lars Egevad, Mark A Rubin, John Nacey, Laurence Klotz, Howard Sandler, Anthony L Zietman, Stuart Holden, Peter A Humphrey, Andrew J Evans, Brett Delahunt, Jesse K McKenney, Daniel Berney, Thomas M Wheeler, Arul Chinnaiyan, Lawrence True, Beatrice Knudsen, Jonathan I Epstein, Mahul B Amin.
Abstract
Active surveillance (AS) is an important management option for men with low-risk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts matures. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and consistently reported by surgical pathologists. This report highlights the importance of accurate pathology reporting as a critical component of these protocols.Entities:
Mesh：
Year: 2014 PMID： 25316188 DOI： 10.1007/s00428-014-1668-5
Source DB: PubMed Journal: Virchows Arch ISSN： 0945-6317 Impact factor: 4.064